Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain

European Journal of Pharmacology

Volumn 324, Issue 1, 1997, Pages 49-56

  Bruggeman, Richard ^a   Westerink, Ben H C ^a   Timmerman, Wia ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Antipsychotic; Basal ganglion; Dopamine; Electrophysiology; Schizophrenia; Substantia nigra reticulate

Indexed keywords

CLOZAPINE; HALOPERIDOL; QUIPAZINE; RISPERIDONE; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA; CLOZAPINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HALOPERIDOL; INJECTIONS, INTRAVENOUS; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RETICULOCYTES; RISPERIDONE; SEROTONIN ANTAGONISTS; SUBSTANTIA NIGRA;

EID: 0031564651     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00054-X     Document Type: Article

References (65)

1. 2 receptors in the medial prefrontal cortex: microiontophoretic studies, Brain Res. 506, 346.
2. Baldessarini, R.J. and D. Tarsy, 1980, Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs, Annu. Rev. Neurosci. 3, 23.
3. Balsara, J.J., J.H. Jadhav and A.G. Chandorkar, 1979, Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy, Psychopharmacology 62, 67.
4. Bethany, S., J.N. Neal-Beliveau, J. Lucki and I. Lucki, 1993, Serotonergic involvement in haloperidol-induced catalepsy, J. Pharmacol. Exp. Ther. 265, 207.
5. 2 antagonist risperidone (R64766) in the treatment of chronic psychosis. An open dose-finding study, Schizophr. Res. 2, 411.
6. Chevalier, G., J.M. Deniau, A.M. Theirry and J. Feger, 1981, The nigro-tectal pathway. An electrophysiological reinvestigation in the rat, Brain Res. 213, 253.
7. Chouinard, G., B. Jones, G. Remington, D. Bloom, D. Addington, G.W. MacEwan, A. Labelle, L. Beauclair and W. Arnott, 1993, A Canadian multicentre placebo-controlled study in fixed doses of risperidone and haloperidol in the treatment of schizophrenic patients, J. Clin. Pharmacol. 13, 25.
8. Claghorn, J., G. Honigfeld, F.S. Abuzzahab, R. Wans, R. Steinbook, V. Tuason and G. Klerman, 1987, The risks and benefits of clozapine versus chlorpromazine, J. Clin. Psychopharmacol. 7, 377.
9. DeLong, M., 1990, Primate models of movement disorders of basal ganglia origin, Trends Neurosci. 13, 281.
10. Deniau, J.M. and G. Chevalier, 1992, The lamellar organization of the rat substantia nigra pars reticulata: distribution of projection neurons, Neuroscience 46, 361.
11. Dray, A., T.J. Gonye, N.R. Oakley and T. Tanner, 1976, Evidence for the existence of a raphe projection to the substantia nigra in rat, Brain Res. 113, 45.
12. Farde, L. and A.L. Nordstrom, 1992, PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients, Br. J. Psychiatry 163, 451.
13. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side-effects, Arch. Gen. Psychiatry 49, 538.
14. Fibiger, H.C. and J.J. Miller, 1977, An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe to the substantia nigra in the rat, Neuroscience 2, 975.
15. Fink, H., R. Morgenstern and W. Oetssner, 1984, Clozapine - a serotonin antagonist? Pharmacol. Biochem. Behav. 20, 513.
16. Fink-Jensen, A. and P. Kristensen, 1994, Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain, Neurosci. Lett. 182, 115.
17. Fuenmayor, L.D. and M. Vogt, 1979, The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain amine depleting neuroleptics or by cholinomimetics, Br. J. Pharmacol. 67, 309.
18. Gelders, Y.G., 1989, Thymosthenic agents, a novel approach in the treatment of schizophrenia, Br. J. Psychiatry 155, 33.
19. Gelders, Y.G., G. VandenBussche, A.J.M. Reyntjens and P.J.M. Janssen, 1986, Serotonin-S2 receptor blockers in the treatment of chronic schizophrenia, Clin. Neuropharmacol. 9, 325.
20. Gellman, R.L. and G.K. Aghajanian, 1994, Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical drugs, Neuroscience 58, 515.
21. Gerfen, Ch.R., K.G. Baimbridge and J.J. Miller, 1985, The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey, Proc. Natl. Acad. Sci. USA 82, 8780.
22. 4 receptors in guinea pig and rat brain, Br. J. Pharmacol. 109, 618.
23. Guyenet, P.G. and G.K. Aghajanian, 1978, Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra, Brain Res. 150, 69.
24. Haracz, J.L., J.T. Tschanz, Z. Wang, I.M. White and G.V. Rebec, 1993, Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats, Neurosci. Biobehav. Rev. 17, 1.
25. Hicks, P.B., 1990, The effect of serotonergic agents on haloperidol-induced catalepsy, Life Sci. 47, 1609.
26. Hikosaka, O. and R.H. Wurtz, 1983, Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of substantia nigra to superior colliculus, J. Neurophysiol. 49, 1285.
27. Kamata, K. and G.V. Rebec, 1985, Nigral reticulata neurons: potentiation of responsiveness to amphetamine with long-term treatment, Brain Res. 332, 188.
28. Kane, J., G. Honigfeld, J. Singer and H. Meltzer, 1988, Clozapine for the treatment-resistent schizophrenic, Arch. Gen. Psychiatry 45, 789.
29. Leysen, J.E., W. Gommeren, A. Eens, D. De Chaffoy de Courcelles, J.C. Stoof and P.A.J. Janssen, 1988, Biochemical profile of risperidone, a new antipsychotic, J. Pharmacol. Exp. Ther. 247, 661.
30. Leysen, J.E., P.F.M. Janssen, W. Gommeren, J. Wynants, P.P. Pauwels and P.A.J. Janssen, 1992, In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotic risperidone and ocaperidone, Mol. Pharmacol. 41, 494.
31. 2 receptors, Psychopharmacology 112, S40.
32. Lynd-Balta, E. and S.N. Haber, 1994, Primate striatonigral projections; a comparison of the sensorimotor-related striatum and the ventral striatum, J. Comp. Neurol. 345, 562.
33. Mathysse, S.W., 1973, Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed. Proc. Am. Soc. Exp. Biol. 32, 200.
34. Meltzer, H.Y., 1989, Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia, Psychopharmacology 99, S18.
35. Meltzer, H.Y., 1995, Role of serotonin in the action of atypical antipsychotic drugs, Clin. Neurosci. 3, 64.
36. Mereu, G., M.G. Corda, P. Corcangiu, O. Giorgi and G. Biggio, 1987, The beta-carboline ZK 93423 inhibits reticulata neurons: an effect reversed by benzodiazepine antagonists, Life Sci. 40, 1423.
37. Nauta, H.J.W. and V.B. Domesick, 1984, Afferent and efferent relationships of the basal ganglia, in: Functions of the Basal Ganglia, eds. A. Evered and M. O'Conner (Pitman, London) p. 3.
38. Nguyen, T.V., B.E. Kosofsky, R. Birnbaum, B.M. Cohen and S.E. Hyman, 1992, Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine and amphetamine, Proc. Natl. Acad. Sci. USA 89, 4270.
39. 2 dopamine receptor occupancy in the living human brain, Psychopharmacology 110, 265.
40. Oberlander, C., P.F. Hunt, C. Dumont and J.R. Boissier, 1981, Dopamine independent rotational response to unilateral injection of serotonin, Life Sci. 28, 2595.
41. Olds, M.E., 1988a, Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine, Neuroscience 24, 465.
42. Olds, M.E., 1988b, Amphetamine-induced increase in motor activity is correlated with higher firing rates of non-dopamine neurons in substantia nigra and ventral tegmental area, Neuroscience 24, 477.
43. Olds, M.E. and A. Yuwiler, 1992, Effects of acute and chronic flenfluramine on self-stimulation and its facilitation by amphetamine, Eur. J. Pharmacol. 216, 363.
44. Paxinos, G. and C. Watson, 1982, The Rat Brain in Stereotaxic Coordinates, 1st edn. (Academic Press, London).
45. Pazos, A., R. Cortes and J.M. Palacios, 1985, Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors, Brain Res. 346, 231.
46. Pazos, A., A. Probst and J.M. Palacios, 1987, Serotonin receptors in the human brain. I. Autoradiographic mapping of serotonin-2 receptors, Neuroscience 21, 123.
47. Rebec, G.V. and P.M. Groves, 1975, Apparent feedback from the caudate nucleus to the substantia nigra following amphetamine administration, Neuropharmacology 14, 275.
48. Rebec, G.V., T.R. Bashore, K.S. Zimmerman and K.S. Alloway, 1979, 'Classical' and 'atypical' antipsychotic drugs: differential antagonism of amphetamine- and apomorphine-induced alterations of spontaneous neuronal activity in the neostriatum and nucleus accumbens, Pharmacol. Biochem. Behav. 11, 529.
49. Rebec, G.V., T.R. Bashore, K.S. Zimmerman and K.S. Alloway, 1980, Neostriatal and mesolimbic neurons: dose-dependent effects of clozapine, Neuropharmacology 19, 281.
50. Rick, C.E., I.M. Stanford and M.G. Lacey, 1995, Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine 2c receptors, Neuroscience 69, 903.
51. Robertson, G.S. and H.C. Fibiger, 1992, Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine, Neuroscience 46, 315.
52. 3 receptors, Life Sci. 50, 599.
53. Roose, K., Y.G. Gelders and S. Heylen, 1988, Risperidone (R64766) in psychotic patients: a first clinical therapeutic exploration, Acta Psychiatr. Belg. 88, 233.
54. Schotte, A., J.M. Maloteaux and P.M. Laduron, 1983, Characterization and regional distribution of serotonin S2-receptors in human brain, Brain Res. 276, 231.
55. Seeman, P. and C. Ulpian, 1983, Neuroleptics have identical potencies in human brain limbic and putamen regions, Eur. J. Pharmacol. 94, 145.
56. Snyder, S.H., 1976, The dopamine hypothesis of schizophrenia: focus on the dopamine receptor, Am. J. Psychiatry 133, 197.
57. Stevens, J.R., 1973, An anatomy of schizophrenia? Arch. Gen. Psychiatry 29, 177.
58. Uno, M., N. Ozawa and M. Yoshida, 1978, The mode of pallido-thalamic transmission investigated with intracellular recording from cat hypothalamus, Exp. Brain Res. 33, 493.
59. Wang, Z. and G.V. Rebec, 1993, Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats, Brain Res. 627, 79.
60. Warenycia, M.W. and G.M. McKenzie, 1984, Immobilization of rats modifies the response of striatal neurons to dexamphetamine, Pharmacol. Biochem. Behav. 21, 53.
61. Waszczak, B.L., N. Eng and J.R. Walters, 1980, Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons, Brain Res. 188, 185.
62. Waszczak, B.L., E.K. Lee, T. Ferraro, T.A. Hare and J.R. Walters, 1984, Single-unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anaesthesia, Brain Res. 306, 307.
63. White, F.J. and R.Y. Wang, 1983, Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons, Science 221, 1054.
64. White, I.M., G.S. Flory, K.C. Hooper, J. Speciale, D.A. Banks and G.V. Rebec, 1995, Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine, J. Neural Transm. 102, 99.
65. 2) receptors in the rat brain, Brain Res. 487, 288.